Use of histamine H3 receptor inverse agonists for the control of appetite and treatment of obesity
申请人:Gliatech, Inc.
公开号:US20030069295A1
公开(公告)日:2003-04-10
A method for the use of histamine H
3
receptor inverse agonists in the regulation of appetite and treatment of obesity is disclosed. Presently preferred inverse agonists are imidazole derivatives.